Evaluation of the Value of Attribution in the Interpretation of Adverse Event Data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group Investigation

PURPOSE: In March 1998, Common Toxicity Criteria (CTC) version 2.0 introduced the collection of attribution of adverse events (AEs) to study drug. We investigate whether attribution adds value to the interpretation of AE data. PATIENTS AND METHODS: Patients in the placebo arm of two phase III trials...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hillman, Shauna L., Mandrekar, Sumithra J., Bot, Brian, DeMatteo, Ronald P., Perez, Edith A., Ballman, Karla V., Nelson, Heidi, Buckner, Jan C., Sargent, Daniel J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2010
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903334/
https://ncbi.nlm.nih.gov/pubmed/20479400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.4282
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi